Mime-Version: |
1.0 |
Sender: |
|
Subject: |
|
From: |
|
Date: |
Sun, 31 Jul 2005 16:10:20 -0400 |
Content-Type: |
text/plain; format=flowed |
Comments: |
|
Reply-To: |
|
Parts/Attachments: |
|
|
Phyllis -- Go to www.iacprx.org/Domperidone, and read the excellent issue
brief from the Int'l Academy of Compounding Pharmacies, written shortly
after the domperidone alert.
FDA regulates mass-marketed drugs. Compounders work on single-patient
prescriptions, written by an appropriate HCP. While FDA issued very scary
cautions about domperidone -- not only to compounders, but directly to OB
offices -- they were just plain out of their jurisdiction.
The snippet from the issue statement reads: "Traditionally, FDA regulates
the manufacturing of drugs and State Boards of Pharmacy regulate the
practice of pharmacy compounding. Compounding differs from manufacturing in
that a compounded medication is prepared and dispensed pursuant to a valid
prescription order from a physician for a specific patient. Manufactured
drugs are mass marketed and distributed through wholesalers and eventually
dispensed through pharmacies to patients unknown to the manufacturer."
Jaye Simpson described in her post the ethical, legal and patient-informing
manner in which to handle discussion of (any) galactagogues with mom.
Liz Brooks, JD, IBCLC
Wyndmoor, PA, USA
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|